Evaluation of quality of life, side effects and duration of therapy in a phase 3 study of intermittent monotherapy versus continuous combined androgen deprivation

F.E. Calais Da Silva; F. Goncalves; A. Santos; J. Kliment; F.M. Calais Da Silva; P. Whelan; T. Oliver; C. Robertson

doi:10.1016/S1569-9056(08)60536-9

Evaluation of quality of life, side effects and duration of therapy in a phase 3 study of intermittent monotherapy versus continuous combined androgen deprivation

F.E. Calais Da Silva, F. Goncalves, A. Santos, J. Kliment, F.M. Calais Da Silva, P. Whelan, T. Oliver, C. Robertson

Mathematics And Statistics

Research output: Contribution to journal › Article › peer-review

Abstract

Introduction & Objectives: We propose this Phase III study comparing the intermittent monotherapy with continuous combined androgen deprivation using an LHRH analogue and ciproterone acetate and associated components of quality of life.

Original language	English
Pages (from-to)	205-205
Number of pages	0
Journal	European Urology Supplements
Volume	7
Issue number	3
DOIs	https://doi.org/10.1016/S1569-9056(08)60536-9
Publication status	Published - Mar 2008

Keywords

evaluation
quality of life
side effects
duration of therapy
phase 3 study
intermittent monotherapy
versus
continuous combined androgen deprivation

Access to Document

10.1016/S1569-9056(08)60536-9

Cite this

Calais Da Silva, F. E., Goncalves, F., Santos, A., Kliment, J., Calais Da Silva, F. M., Whelan, P., Oliver, T., & Robertson, C. (2008). Evaluation of quality of life, side effects and duration of therapy in a phase 3 study of intermittent monotherapy versus continuous combined androgen deprivation. European Urology Supplements, 7(3), 205-205. https://doi.org/10.1016/S1569-9056(08)60536-9

@article{c659786ffe794432bebbdb7e40d01512,

title = "Evaluation of quality of life, side effects and duration of therapy in a phase 3 study of intermittent monotherapy versus continuous combined androgen deprivation",

abstract = "Introduction \& Objectives: We propose this Phase III study comparing the intermittent monotherapy with continuous combined androgen deprivation using an LHRH analogue and ciproterone acetate and associated components of quality of life.",

keywords = "evaluation, quality of life, side effects, duration of therapy, phase 3 study, intermittent monotherapy, versus, continuous combined androgen deprivation",

author = "\{Calais Da Silva\}, F.E. and F. Goncalves and A. Santos and J. Kliment and \{Calais Da Silva\}, F.M. and P. Whelan and T. Oliver and C. Robertson",

note = "Strathprints' policy is to record up to 8 authors per publication, plus any additional authors based at the University of Strathclyde. More authors may be listed on the official publication than appear in the Strathprints' record. http://suprimo.lib.strath.ac.uk/primo\_library/libweb/action/search.do?scp.scps=scope\%3A(SU)\&srt=rank\&tab=local\&mode=Basic\&dum=true\&fn=search\&frbg=\&dstmp=1273159714928\&dscnt=0\&ct=search\&vid=SUVU01\&indx=1\&vl(freeText0)=European\%20urology\%20supplements\&vl(54032236UI0)=lsr02\&vl(96071691UI1)=all\_items",

year = "2008",

month = mar,

doi = "10.1016/S1569-9056(08)60536-9",

language = "English",

volume = "7",

pages = "205--205",

journal = "European Urology Supplements",

issn = "1569-9056",

number = "3",

}

Calais Da Silva, FE, Goncalves, F, Santos, A, Kliment, J, Calais Da Silva, FM, Whelan, P, Oliver, T & Robertson, C 2008, 'Evaluation of quality of life, side effects and duration of therapy in a phase 3 study of intermittent monotherapy versus continuous combined androgen deprivation', European Urology Supplements, vol. 7, no. 3, pp. 205-205. https://doi.org/10.1016/S1569-9056(08)60536-9

TY - JOUR

T1 - Evaluation of quality of life, side effects and duration of therapy in a phase 3 study of intermittent monotherapy versus continuous combined androgen deprivation

AU - Calais Da Silva, F.E.

AU - Goncalves, F.

AU - Santos, A.

AU - Kliment, J.

AU - Calais Da Silva, F.M.

AU - Whelan, P.

AU - Oliver, T.

AU - Robertson, C.

N1 - Strathprints' policy is to record up to 8 authors per publication, plus any additional authors based at the University of Strathclyde. More authors may be listed on the official publication than appear in the Strathprints' record. http://suprimo.lib.strath.ac.uk/primo_library/libweb/action/search.do?scp.scps=scope%3A(SU)&srt=rank&tab=local&mode=Basic&dum=true&fn=search&frbg=&dstmp=1273159714928&dscnt=0&ct=search&vid=SUVU01&indx=1&vl(freeText0)=European%20urology%20supplements&vl(54032236UI0)=lsr02&vl(96071691UI1)=all_items

PY - 2008/3

Y1 - 2008/3

N2 - Introduction & Objectives: We propose this Phase III study comparing the intermittent monotherapy with continuous combined androgen deprivation using an LHRH analogue and ciproterone acetate and associated components of quality of life.

AB - Introduction & Objectives: We propose this Phase III study comparing the intermittent monotherapy with continuous combined androgen deprivation using an LHRH analogue and ciproterone acetate and associated components of quality of life.

KW - evaluation

KW - quality of life

KW - side effects

KW - duration of therapy

KW - phase 3 study

KW - intermittent monotherapy

KW - versus

KW - continuous combined androgen deprivation

UR - http://dx.doi.org/10.1016/S1569-9056(08)60536-9

U2 - 10.1016/S1569-9056(08)60536-9

DO - 10.1016/S1569-9056(08)60536-9

M3 - Article

SN - 1569-9056

VL - 7

SP - 205

EP - 205

JO - European Urology Supplements

JF - European Urology Supplements

IS - 3

ER -

Evaluation of quality of life, side effects and duration of therapy in a phase 3 study of intermittent monotherapy versus continuous combined androgen deprivation

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this